0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lisinopril Tablets Market Research Report 2022
Published Date: August 2022
|
Report Code: QYRE-Auto-4W11860
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Lisinopril Tablets Market Research Report 2022

Global Lisinopril Tablets Market Research Report 2022

Code: QYRE-Auto-4W11860
Report
August 2022
101 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Highlights

The global Lisinopril Tablets market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

North American market for Lisinopril Tablets is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for Lisinopril Tablets is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The major global manufacturers of Lisinopril Tablets include Shanghai Sine WANXIANG Pharmaceuticals, ZHONGFU Pharmaceutical, Ningbo Menovo TianKang Pharmaceutical, Shanghai Great Wall Pharmaceutical, Sinopharm Shantou Jinshi Pharmaceutical, Jiangsu Huanghe Medical, Yichang HEC Changjiang Pharmaceutical, Hebei Wansui Pharmaceutical and Jincheng Haisi Pharmaceutical, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.

The global market for Lisinopril Tablets in Hospital Pharmacy is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, 5mg/Tablet, which accounted for % of the global market of Lisinopril Tablets in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Lisinopril Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lisinopril Tablets.
The Lisinopril Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Lisinopril Tablets market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lisinopril Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Shanghai Sine WANXIANG Pharmaceuticals
ZHONGFU Pharmaceutical
Ningbo Menovo TianKang Pharmaceutical
Shanghai Great Wall Pharmaceutical
Sinopharm Shantou Jinshi Pharmaceutical
Jiangsu Huanghe Medical
Yichang HEC Changjiang Pharmaceutical
Hebei Wansui Pharmaceutical
Jincheng Haisi Pharmaceutical
Jiangsu Kanion Pharmaceutical
Zhejiang Huahai Pharmaceutical
Facmed Pharmaceuticals
Crescent
Bristol
Actavis
Healing Pharma
TAJ Pharma
Product Type Insights
Global markets are presented by Lisinopril Tablets type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Lisinopril Tablets are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Lisinopril Tablets segment by Specification
5mg/Tablet
10mg/Tablet
20mg/Tablet
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Lisinopril Tablets market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Lisinopril Tablets market.

Lisinopril Tablets segment by Application

Hospital Pharmacy
Retail Pharmacy
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Lisinopril Tablets market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lisinopril Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Lisinopril Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Lisinopril Tablets industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lisinopril Tablets.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lisinopril Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lisinopril Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
1 Lisinopril Tablets Market Overview
1.1 Product Overview and Scope of Lisinopril Tablets
1.2 Lisinopril Tablets Segment by Specification
1.2.1 Global Lisinopril Tablets Sales Growth Rate Comparison by Specification (2022-2028)
1.2.2 5mg/Tablet
1.2.3 10mg/Tablet
1.2.4 20mg/Tablet
1.3 Lisinopril Tablets Segment by Application
1.3.1 Global Lisinopril Tablets Sales Comparison by Application: (2022-2028)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Lisinopril Tablets Market Size Estimates and Forecasts
1.4.1 Global Lisinopril Tablets Revenue 2017-2028
1.4.2 Global Lisinopril Tablets Sales 2017-2028
1.4.3 Lisinopril Tablets Market Size by Region: 2017 Versus 2021 Versus 2028
2 Lisinopril Tablets Market Competition by Manufacturers
2.1 Global Lisinopril Tablets Sales Market Share by Manufacturers (2017-2022)
2.2 Global Lisinopril Tablets Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Lisinopril Tablets Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Lisinopril Tablets Manufacturing Sites, Area Served, Product Type
2.5 Lisinopril Tablets Market Competitive Situation and Trends
2.5.1 Lisinopril Tablets Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Lisinopril Tablets Players Market Share by Revenue
2.5.3 Global Lisinopril Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lisinopril Tablets Retrospective Market Scenario by Region
3.1 Global Lisinopril Tablets Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Lisinopril Tablets Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Lisinopril Tablets Market Facts & Figures by Country
3.3.1 North America Lisinopril Tablets Sales by Country
3.3.2 North America Lisinopril Tablets Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Lisinopril Tablets Market Facts & Figures by Country
3.4.1 Europe Lisinopril Tablets Sales by Country
3.4.2 Europe Lisinopril Tablets Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Lisinopril Tablets Market Facts & Figures by Region
3.5.1 Asia Pacific Lisinopril Tablets Sales by Region
3.5.2 Asia Pacific Lisinopril Tablets Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Lisinopril Tablets Market Facts & Figures by Country
3.6.1 Latin America Lisinopril Tablets Sales by Country
3.6.2 Latin America Lisinopril Tablets Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Lisinopril Tablets Market Facts & Figures by Country
3.7.1 Middle East and Africa Lisinopril Tablets Sales by Country
3.7.2 Middle East and Africa Lisinopril Tablets Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Lisinopril Tablets Historic Market Analysis by Specification
4.1 Global Lisinopril Tablets Sales Market Share by Specification (2017-2022)
4.2 Global Lisinopril Tablets Revenue Market Share by Specification (2017-2022)
4.3 Global Lisinopril Tablets Price by Specification (2017-2022)
5 Global Lisinopril Tablets Historic Market Analysis by Application
5.1 Global Lisinopril Tablets Sales Market Share by Application (2017-2022)
5.2 Global Lisinopril Tablets Revenue Market Share by Application (2017-2022)
5.3 Global Lisinopril Tablets Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Shanghai Sine WANXIANG Pharmaceuticals
6.1.1 Shanghai Sine WANXIANG Pharmaceuticals Corporation Information
6.1.2 Shanghai Sine WANXIANG Pharmaceuticals Description and Business Overview
6.1.3 Shanghai Sine WANXIANG Pharmaceuticals Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Shanghai Sine WANXIANG Pharmaceuticals Lisinopril Tablets Product Portfolio
6.1.5 Shanghai Sine WANXIANG Pharmaceuticals Recent Developments/Updates
6.2 ZHONGFU Pharmaceutical
6.2.1 ZHONGFU Pharmaceutical Corporation Information
6.2.2 ZHONGFU Pharmaceutical Description and Business Overview
6.2.3 ZHONGFU Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.2.4 ZHONGFU Pharmaceutical Lisinopril Tablets Product Portfolio
6.2.5 ZHONGFU Pharmaceutical Recent Developments/Updates
6.3 Ningbo Menovo TianKang Pharmaceutical
6.3.1 Ningbo Menovo TianKang Pharmaceutical Corporation Information
6.3.2 Ningbo Menovo TianKang Pharmaceutical Description and Business Overview
6.3.3 Ningbo Menovo TianKang Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Ningbo Menovo TianKang Pharmaceutical Lisinopril Tablets Product Portfolio
6.3.5 Ningbo Menovo TianKang Pharmaceutical Recent Developments/Updates
6.4 Shanghai Great Wall Pharmaceutical
6.4.1 Shanghai Great Wall Pharmaceutical Corporation Information
6.4.2 Shanghai Great Wall Pharmaceutical Description and Business Overview
6.4.3 Shanghai Great Wall Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Shanghai Great Wall Pharmaceutical Lisinopril Tablets Product Portfolio
6.4.5 Shanghai Great Wall Pharmaceutical Recent Developments/Updates
6.5 Sinopharm Shantou Jinshi Pharmaceutical
6.5.1 Sinopharm Shantou Jinshi Pharmaceutical Corporation Information
6.5.2 Sinopharm Shantou Jinshi Pharmaceutical Description and Business Overview
6.5.3 Sinopharm Shantou Jinshi Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Sinopharm Shantou Jinshi Pharmaceutical Lisinopril Tablets Product Portfolio
6.5.5 Sinopharm Shantou Jinshi Pharmaceutical Recent Developments/Updates
6.6 Jiangsu Huanghe Medical
6.6.1 Jiangsu Huanghe Medical Corporation Information
6.6.2 Jiangsu Huanghe Medical Description and Business Overview
6.6.3 Jiangsu Huanghe Medical Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Jiangsu Huanghe Medical Lisinopril Tablets Product Portfolio
6.6.5 Jiangsu Huanghe Medical Recent Developments/Updates
6.7 Yichang HEC Changjiang Pharmaceutical
6.6.1 Yichang HEC Changjiang Pharmaceutical Corporation Information
6.6.2 Yichang HEC Changjiang Pharmaceutical Description and Business Overview
6.6.3 Yichang HEC Changjiang Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Yichang HEC Changjiang Pharmaceutical Lisinopril Tablets Product Portfolio
6.7.5 Yichang HEC Changjiang Pharmaceutical Recent Developments/Updates
6.8 Hebei Wansui Pharmaceutical
6.8.1 Hebei Wansui Pharmaceutical Corporation Information
6.8.2 Hebei Wansui Pharmaceutical Description and Business Overview
6.8.3 Hebei Wansui Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Hebei Wansui Pharmaceutical Lisinopril Tablets Product Portfolio
6.8.5 Hebei Wansui Pharmaceutical Recent Developments/Updates
6.9 Jincheng Haisi Pharmaceutical
6.9.1 Jincheng Haisi Pharmaceutical Corporation Information
6.9.2 Jincheng Haisi Pharmaceutical Description and Business Overview
6.9.3 Jincheng Haisi Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Jincheng Haisi Pharmaceutical Lisinopril Tablets Product Portfolio
6.9.5 Jincheng Haisi Pharmaceutical Recent Developments/Updates
6.10 Jiangsu Kanion Pharmaceutical
6.10.1 Jiangsu Kanion Pharmaceutical Corporation Information
6.10.2 Jiangsu Kanion Pharmaceutical Description and Business Overview
6.10.3 Jiangsu Kanion Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Jiangsu Kanion Pharmaceutical Lisinopril Tablets Product Portfolio
6.10.5 Jiangsu Kanion Pharmaceutical Recent Developments/Updates
6.11 Zhejiang Huahai Pharmaceutical
6.11.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.11.2 Zhejiang Huahai Pharmaceutical Lisinopril Tablets Description and Business Overview
6.11.3 Zhejiang Huahai Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Zhejiang Huahai Pharmaceutical Lisinopril Tablets Product Portfolio
6.11.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.12 Facmed Pharmaceuticals
6.12.1 Facmed Pharmaceuticals Corporation Information
6.12.2 Facmed Pharmaceuticals Lisinopril Tablets Description and Business Overview
6.12.3 Facmed Pharmaceuticals Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Facmed Pharmaceuticals Lisinopril Tablets Product Portfolio
6.12.5 Facmed Pharmaceuticals Recent Developments/Updates
6.13 Crescent
6.13.1 Crescent Corporation Information
6.13.2 Crescent Lisinopril Tablets Description and Business Overview
6.13.3 Crescent Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Crescent Lisinopril Tablets Product Portfolio
6.13.5 Crescent Recent Developments/Updates
6.14 Bristol
6.14.1 Bristol Corporation Information
6.14.2 Bristol Lisinopril Tablets Description and Business Overview
6.14.3 Bristol Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Bristol Lisinopril Tablets Product Portfolio
6.14.5 Bristol Recent Developments/Updates
6.15 Actavis
6.15.1 Actavis Corporation Information
6.15.2 Actavis Lisinopril Tablets Description and Business Overview
6.15.3 Actavis Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Actavis Lisinopril Tablets Product Portfolio
6.15.5 Actavis Recent Developments/Updates
6.16 Healing Pharma
6.16.1 Healing Pharma Corporation Information
6.16.2 Healing Pharma Lisinopril Tablets Description and Business Overview
6.16.3 Healing Pharma Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Healing Pharma Lisinopril Tablets Product Portfolio
6.16.5 Healing Pharma Recent Developments/Updates
6.17 TAJ Pharma
6.17.1 TAJ Pharma Corporation Information
6.17.2 TAJ Pharma Lisinopril Tablets Description and Business Overview
6.17.3 TAJ Pharma Lisinopril Tablets Sales, Revenue and Gross Margin (2017-2022)
6.17.4 TAJ Pharma Lisinopril Tablets Product Portfolio
6.17.5 TAJ Pharma Recent Developments/Updates
7 Lisinopril Tablets Manufacturing Cost Analysis
7.1 Lisinopril Tablets Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Lisinopril Tablets
7.4 Lisinopril Tablets Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Lisinopril Tablets Distributors List
8.3 Lisinopril Tablets Customers
9 Lisinopril Tablets Market Dynamics
9.1 Lisinopril Tablets Industry Trends
9.2 Lisinopril Tablets Market Drivers
9.3 Lisinopril Tablets Market Challenges
9.4 Lisinopril Tablets Market Restraints
10 Global Market Forecast
10.1 Lisinopril Tablets Market Estimates and Projections by Specification
10.1.1 Global Forecasted Sales of Lisinopril Tablets by Specification (2023-2028)
10.1.2 Global Forecasted Revenue of Lisinopril Tablets by Specification (2023-2028)
10.2 Lisinopril Tablets Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Lisinopril Tablets by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Lisinopril Tablets by Application (2023-2028)
10.3 Lisinopril Tablets Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Lisinopril Tablets by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Lisinopril Tablets by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
    Table 1. Global Lisinopril Tablets Sales Growth Rate Comparison by Specification (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Lisinopril Tablets Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Lisinopril Tablets Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Lisinopril Tablets Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Lisinopril Tablets Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Lisinopril Tablets Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Lisinopril Tablets Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Lisinopril Tablets Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Lisinopril Tablets Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Lisinopril Tablets Manufacturing Sites and Area Served
    Table 11. Manufacturers Lisinopril Tablets Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Lisinopril Tablets by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lisinopril Tablets as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Lisinopril Tablets Sales by Region (2017-2022) & (K Units)
    Table 16. Global Lisinopril Tablets Sales Market Share by Region (2017-2022)
    Table 17. Global Lisinopril Tablets Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Lisinopril Tablets Revenue Market Share by Region (2017-2022)
    Table 19. North America Lisinopril Tablets Sales by Country (2017-2022) & (K Units)
    Table 20. North America Lisinopril Tablets Sales Market Share by Country (2017-2022)
    Table 21. North America Lisinopril Tablets Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Lisinopril Tablets Revenue Market Share by Country (2017-2022)
    Table 23. Europe Lisinopril Tablets Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Lisinopril Tablets Sales Market Share by Country (2017-2022)
    Table 25. Europe Lisinopril Tablets Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Lisinopril Tablets Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Lisinopril Tablets Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Lisinopril Tablets Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Lisinopril Tablets Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Lisinopril Tablets Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Lisinopril Tablets Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Lisinopril Tablets Sales Market Share by Country (2017-2022)
    Table 33. Latin America Lisinopril Tablets Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Lisinopril Tablets Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Lisinopril Tablets Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Lisinopril Tablets Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Lisinopril Tablets Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Lisinopril Tablets Revenue Market Share by Country (2017-2022)
    Table 39. Global Lisinopril Tablets Sales by Specification (2017-2022) & (K Units)
    Table 40. Global Lisinopril Tablets Sales Market Share by Specification (2017-2022)
    Table 41. Global Lisinopril Tablets Revenue by Specification (2017-2022) & (US$ Million)
    Table 42. Global Lisinopril Tablets Revenue Share by Specification (2017-2022)
    Table 43. Global Lisinopril Tablets Price by Specification (2017-2022) & (US$/Unit)
    Table 44. Global Lisinopril Tablets Sales (K Units) by Application (2017-2022)
    Table 45. Global Lisinopril Tablets Sales Market Share by Application (2017-2022)
    Table 46. Global Lisinopril Tablets Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Lisinopril Tablets Revenue Share by Application (2017-2022)
    Table 48. Global Lisinopril Tablets Price by Application (2017-2022) & (US$/Unit)
    Table 49. Shanghai Sine WANXIANG Pharmaceuticals Corporation Information
    Table 50. Shanghai Sine WANXIANG Pharmaceuticals Description and Business Overview
    Table 51. Shanghai Sine WANXIANG Pharmaceuticals Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Shanghai Sine WANXIANG Pharmaceuticals Lisinopril Tablets Product
    Table 53. Shanghai Sine WANXIANG Pharmaceuticals Recent Developments/Updates
    Table 54. ZHONGFU Pharmaceutical Corporation Information
    Table 55. ZHONGFU Pharmaceutical Description and Business Overview
    Table 56. ZHONGFU Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. ZHONGFU Pharmaceutical Lisinopril Tablets Product
    Table 58. ZHONGFU Pharmaceutical Recent Developments/Updates
    Table 59. Ningbo Menovo TianKang Pharmaceutical Corporation Information
    Table 60. Ningbo Menovo TianKang Pharmaceutical Description and Business Overview
    Table 61. Ningbo Menovo TianKang Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Ningbo Menovo TianKang Pharmaceutical Lisinopril Tablets Product
    Table 63. Ningbo Menovo TianKang Pharmaceutical Recent Developments/Updates
    Table 64. Shanghai Great Wall Pharmaceutical Corporation Information
    Table 65. Shanghai Great Wall Pharmaceutical Description and Business Overview
    Table 66. Shanghai Great Wall Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Shanghai Great Wall Pharmaceutical Lisinopril Tablets Product
    Table 68. Shanghai Great Wall Pharmaceutical Recent Developments/Updates
    Table 69. Sinopharm Shantou Jinshi Pharmaceutical Corporation Information
    Table 70. Sinopharm Shantou Jinshi Pharmaceutical Description and Business Overview
    Table 71. Sinopharm Shantou Jinshi Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Sinopharm Shantou Jinshi Pharmaceutical Lisinopril Tablets Product
    Table 73. Sinopharm Shantou Jinshi Pharmaceutical Recent Developments/Updates
    Table 74. Jiangsu Huanghe Medical Corporation Information
    Table 75. Jiangsu Huanghe Medical Description and Business Overview
    Table 76. Jiangsu Huanghe Medical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Jiangsu Huanghe Medical Lisinopril Tablets Product
    Table 78. Jiangsu Huanghe Medical Recent Developments/Updates
    Table 79. Yichang HEC Changjiang Pharmaceutical Corporation Information
    Table 80. Yichang HEC Changjiang Pharmaceutical Description and Business Overview
    Table 81. Yichang HEC Changjiang Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Yichang HEC Changjiang Pharmaceutical Lisinopril Tablets Product
    Table 83. Yichang HEC Changjiang Pharmaceutical Recent Developments/Updates
    Table 84. Hebei Wansui Pharmaceutical Corporation Information
    Table 85. Hebei Wansui Pharmaceutical Description and Business Overview
    Table 86. Hebei Wansui Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Hebei Wansui Pharmaceutical Lisinopril Tablets Product
    Table 88. Hebei Wansui Pharmaceutical Recent Developments/Updates
    Table 89. Jincheng Haisi Pharmaceutical Corporation Information
    Table 90. Jincheng Haisi Pharmaceutical Description and Business Overview
    Table 91. Jincheng Haisi Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Jincheng Haisi Pharmaceutical Lisinopril Tablets Product
    Table 93. Jincheng Haisi Pharmaceutical Recent Developments/Updates
    Table 94. Jiangsu Kanion Pharmaceutical Corporation Information
    Table 95. Jiangsu Kanion Pharmaceutical Description and Business Overview
    Table 96. Jiangsu Kanion Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Jiangsu Kanion Pharmaceutical Lisinopril Tablets Product
    Table 98. Jiangsu Kanion Pharmaceutical Recent Developments/Updates
    Table 99. Zhejiang Huahai Pharmaceutical Corporation Information
    Table 100. Zhejiang Huahai Pharmaceutical Description and Business Overview
    Table 101. Zhejiang Huahai Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Zhejiang Huahai Pharmaceutical Lisinopril Tablets Product
    Table 103. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
    Table 104. Facmed Pharmaceuticals Corporation Information
    Table 105. Facmed Pharmaceuticals Description and Business Overview
    Table 106. Facmed Pharmaceuticals Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. Facmed Pharmaceuticals Lisinopril Tablets Product
    Table 108. Facmed Pharmaceuticals Recent Developments/Updates
    Table 109. Crescent Corporation Information
    Table 110. Crescent Description and Business Overview
    Table 111. Crescent Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Crescent Lisinopril Tablets Product
    Table 113. Crescent Recent Developments/Updates
    Table 114. Bristol Corporation Information
    Table 115. Bristol Description and Business Overview
    Table 116. Bristol Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. Bristol Lisinopril Tablets Product
    Table 118. Bristol Recent Developments/Updates
    Table 119. Actavis Corporation Information
    Table 120. Actavis Description and Business Overview
    Table 121. Actavis Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 122. Actavis Lisinopril Tablets Product
    Table 123. Actavis Recent Developments/Updates
    Table 124. Healing Pharma Corporation Information
    Table 125. Healing Pharma Description and Business Overview
    Table 126. Healing Pharma Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 127. Healing Pharma Lisinopril Tablets Product
    Table 128. Healing Pharma Recent Developments/Updates
    Table 129. TAJ Pharma Corporation Information
    Table 130. TAJ Pharma Description and Business Overview
    Table 131. TAJ Pharma Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 132. TAJ Pharma Lisinopril Tablets Product
    Table 133. TAJ Pharma Recent Developments/Updates
    Table 134. Production Base and Market Concentration Rate of Raw Material
    Table 135. Key Suppliers of Raw Materials
    Table 136. Lisinopril Tablets Distributors List
    Table 137. Lisinopril Tablets Customers List
    Table 138. Lisinopril Tablets Market Trends
    Table 139. Lisinopril Tablets Market Drivers
    Table 140. Lisinopril Tablets Market Challenges
    Table 141. Lisinopril Tablets Market Restraints
    Table 142. Global Lisinopril Tablets Sales Forecast by Specification (2023-2028) & (K Units)
    Table 143. Global Lisinopril Tablets Sales Market Share Forecast by Specification (2023-2028)
    Table 144. Global Lisinopril Tablets Revenue Forecast by Specification (2023-2028) & (US$ Million)
    Table 145. Global Lisinopril Tablets Revenue Market Share Forecast by Specification (2023-2028)
    Table 146. Global Lisinopril Tablets Sales Forecast by Application (2023-2028) & (K Units)
    Table 147. Global Lisinopril Tablets Sales Market Share Forecast by Application (2023-2028)
    Table 148. Global Lisinopril Tablets Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 149. Global Lisinopril Tablets Revenue Market Share Forecast by Application (2023-2028)
    Table 150. Global Lisinopril Tablets Sales Forecast by Region (2023-2028) & (K Units)
    Table 151. Global Lisinopril Tablets Sales Market Share Forecast by Region (2023-2028)
    Table 152. Global Lisinopril Tablets Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 153. Global Lisinopril Tablets Revenue Market Share Forecast by Region (2023-2028)
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Lisinopril Tablets
    Figure 2. Global Lisinopril Tablets Market Share by Specification in 2021 & 2028
    Figure 3. 5mg/Tablet Product Picture
    Figure 4. 10mg/Tablet Product Picture
    Figure 5. 20mg/Tablet Product Picture
    Figure 6. Global Lisinopril Tablets Market Share by Application in 2021 & 2028
    Figure 7. Hospital Pharmacy
    Figure 8. Retail Pharmacy
    Figure 9. Others
    Figure 10. Global Lisinopril Tablets Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Lisinopril Tablets Market Size (2017-2028) & (US$ Million)
    Figure 12. Global Lisinopril Tablets Sales (2017-2028) & (K Units)
    Figure 13. Lisinopril Tablets Sales Share by Manufacturers in 2021
    Figure 14. Global Lisinopril Tablets Revenue Share by Manufacturers in 2021
    Figure 15. The Global 5 and 10 Largest Lisinopril Tablets Players: Market Share by Revenue in 2021
    Figure 16. Lisinopril Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Lisinopril Tablets Sales Market Share by Region (2017-2022)
    Figure 18. Global Lisinopril Tablets Sales Market Share by Region in 2021
    Figure 19. Global Lisinopril Tablets Revenue Market Share by Region (2017-2022)
    Figure 20. Global Lisinopril Tablets Revenue Market Share by Region in 2021
    Figure 21. United States Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Canada Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Germany Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. France Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. U.K. Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Italy Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Russia Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. China Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Japan Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. South Korea Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. India Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Australia Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. China Taiwan Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Indonesia Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Thailand Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Malaysia Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Mexico Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Brazil Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Argentina Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Turkey Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Saudi Arabia Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. UAE Lisinopril Tablets Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Sales Market Share of Lisinopril Tablets by Specification (2017-2022)
    Figure 44. Manufacturing Cost Structure of Lisinopril Tablets
    Figure 45. Manufacturing Process Analysis of Lisinopril Tablets
    Figure 46. Lisinopril Tablets Industrial Chain Analysis
    Figure 47. Channels of Distribution
    Figure 48. Distributors Profiles
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user to access the PDF.

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network
SIMILAR REPORTS